Paper Details

  1. Home
  2. Paper Details

Palliative endobronchial brachytherapy for non-small cell lung cancer.

Author: CardonaA F, OspinaE G, OspinaV, ReveizL, YepesA

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Endobronchial brachytherapy (EBB) is being used to improve local control of non-small cell lung cancers (NSCLC).
Paper Details　
Original Abstract of the Article :
Non-small cell lung cancers (NSCLC) constitutes about 80% of all lung cancer cases. Although surgery is the only curative treatment of NSCLC, fewer than 20% of tumors can be radically resected. Radiotherapy is one of the main treatment modalities in lung cancer, contributing to both its cure and pal...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD004284.pub2

データ提供：米国国立医学図書館（NLM）

Palliative Endobronchial Brachytherapy for Lung Cancer: A Glimpse of Hope

Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide. While surgery is the only curative treatment for NSCLC, less than 20% of tumors are amenable to radical resection. This research, published in Lung Cancer, explores the role of palliative endobronchial brachytherapy (EBB) for NSCLC patients. EBB involves the placement of radioactive seeds directly into the tumor, aiming to improve local control and provide symptom relief. The authors discuss the use of EBB, either alone or in combination with other treatments, as a potential approach for managing NSCLC.

A New Oasis in the Desert of Lung Cancer: Exploring EBB

This research explores the potential of EBB as a palliative treatment option for NSCLC patients, highlighting its role in improving local control and providing symptom relief. The authors emphasize the importance of considering EBB as a potential approach for managing this challenging disease.

Finding Relief in the Desert: Navigating Lung Cancer

This study offers hope for patients with NSCLC by exploring the potential of EBB as a palliative treatment option. Patients with NSCLC should consult with an oncologist to discuss the various treatment options available, ensuring that they have access to the information needed to make informed decisions about their care.

Dr. Camel's Conclusion

Lung cancer can feel like a vast, unforgiving desert, but this research offers a glimmer of hope in the form of palliative endobronchial brachytherapy. EBB provides a potential oasis for patients seeking relief from symptoms and improved local control, offering a more comfortable and manageable journey through this challenging illness.
Date :
  1. Date Completed 2008-06-13
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

18425900

DOI: Digital Object Identifier

10.1002/14651858.CD004284.pub2

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.